13.50p+0.50 (+3.85%)22 Jul 2025, 16:35
Jump to:
Creo Medical Group PLC Fundamentals
Company Name | Creo Medical Group PLC | Last Updated | 2025-07-22 |
---|---|---|---|
Industry | Medical Devices | Sector | Healthcare |
Shares in Issue | 412.473 m | Market Cap | £55.68 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -£0.08 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0.0677 | Debt Equity Ratio | 0.0472 |
Asset Equity Ratio | 1.5330 | Cash Equity Ratio | 0.2052 |
Quick Ratio | 0.4878 | Current Ratio | 2.75 |
Price To Book Value | 1.2647 | ROCE | 0 |
Creo Medical Group PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Creo Medical Group PLC Company Financials
Assets | 2024 | 2023 | 2022 |
---|---|---|---|
Tangible Assets | £5.90 m | £9.10 m | £10.20 m |
Intangible Assets | £500,000.00 | £26.20 m | £27.60 m |
Investments | £2.10 m | £2.10 m | £2.10 m |
Total Fixed Assets | £8.60 m | £38.70 m | £41.60 m |
Stocks | £2.70 m | £8.10 m | £9.30 m |
Debtors | £1.30 m | £7.90 m | £5.60 m |
Cash & Equivalents | £8.70 m | £18.50 m | £13.10 m |
Other Assets | £100,000.00 | £1.30 m | £1.70 m |
Total Assets | £65.00 m | £76.60 m | £75.20 m |
Liabilities | 2024 | 2023 | 2022 |
---|---|---|---|
Creditors within 1 year | £20.50 m | £9.90 m | £17.40 m |
Creditors after 1 year | £2.10 m | £6.90 m | £8.50 m |
Other Liabilities | £14.20 m | 0 | 0 |
Total Liabilities | £22.60 m | £16.80 m | £25.90 m |
Net assets | £42.40 m | £59.80 m | £49.30 m |
Equity | 2024 | 2023 | 2022 |
---|---|---|---|
Called up share capital | £400,000.00 | £400,000.00 | £200,000.00 |
Share Premium | £192.00 m | £180.90 m | £149.50 m |
Profit / Loss | -£29.00 m | -£26.40 m | -£30.90 m |
Other Equity | £42.40 m | £59.80 m | £49.30 m |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | £42.40 m | £59.80 m | £49.30 m |
Ratios | 2024 | 2023 | 2022 |
---|---|---|---|
Debt Ratio | £0.05 | £0.08 | £0.11 |
Debt-to-Equity | £0.05 | £0.09 | £0.12 |
Assets / Equity | 1.5330 | 1.5330 | 1.5330 |
Cash / Equity | 0.2052 | 0.2052 | 0.2052 |
EPS | -£0.08 | -£0.08 | -£0.14 |
Cash Flow | 2024 | 2023 | 2022 |
---|---|---|---|
Cash from operating activities | -£22.20 m | -£21.60 m | -£24.90 m |
Cashflow before financing | -£6.00 m | £8.20 m | -£24.50 m |
Increase in Cash | £9.30 m | -£10.10 m | -£30.50 m |
Income | 2024 | 2023 | 2022 |
---|---|---|---|
Turnover | £4.00 m | £4.00 m | £27.20 m |
Cost of sales | £2.10 m | £1.70 m | £14.00 m |
Gross Profit | £1.90 m | £2.30 m | £13.20 m |
Operating Profit | -£28.80 m | -£26.90 m | -£30.70 m |
Pre-Tax profit | -£29.00 m | -£26.40 m | -£30.90 m |
Creo Medical Group PLC Company Background
Sector | Healthcare |
---|---|
Activities | Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world. |
Latest Interim Date | 30 Sep 2024 |
Latest Fiscal Year End Date | 19 May 2025 |
Creo Medical Group PLC Directors
Appointed | Name | Position |
---|---|---|
2025-05-30 | Mr. John Bradshaw | Non-Executive Director,Senior Independent Non-Executive Director |
2024-06-28 | Dr. Charles Alexander Evan Spicer | Non-Executive Director,Chairman |
2025-03-26 | Mr. Craig Jonathan Gulliford | Executive Director,Chief Executive Officer |
2025-03-26 | Mr. Richard John Rees | Executive Director,Chief Financial Officer and Company Secretary |
2025-06-26 | Professor Christopher Paul Hancock | Executive Director,Chief Technology Officer |
2025-06-26 | Mr. David Gerard Woods | Executive Director,Chief Commercial Officer |
2025-06-02 | Mr. Kevin Timothy Crofton | Non-Executive Director,Chairman |
2025-05-30 | Ms. Ivonne Maria Gloria Cantu | Non-Executive Director |
Creo Medical Group PLC Contact Details
Company Name | Creo Medical Group PLC |
---|---|
Address | Beaufort Park Way, Unit 2, Creo House, Chepstow, NP16 5UH |
Telephone | +44 1291606005 |
Website | https://www.creomedical.com |
Creo Medical Group PLC Advisors
Solicitor | Taylor Wessing LLP |
---|---|
Phone | +44 2073007000 |
Fax | +44 2073007100 |
Auditor | KPMG |
---|---|
Phone | +44 01179054000 |
Fax | +44 01179054001 |
Registrar | Equiniti Limited |
---|---|
Phone | +44 3713842030 |
Fax | +44 3713842100 |
Financial PR Adviser | FTI Consulting Inc |
---|---|
Phone | +44 2037271000 |
Fax | +44 2037271007 |
Stockbroker | Cenkos Securities |
---|---|
Phone | +44 2073978900 |
Fax | +44 2073978901 |
Nominated Adviser | Cenkos Securities |
---|---|
Phone | +44 2073978900 |
Fax | +44 2073978901 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Greencore Group PLC | 267.50 | 11.00 |
Bakkavor Group PLC | 239.07 | 7.69 |
Compass Group PLC | 2,660.00 | 5.39 |
Centrica PLC | 163.55 | 4.40 |
Ocean Wilsons (Holdings) LD | 1,460.00 | 4.29 |
Oxford Nanopore Technologies PLC | 181.70 | 3.95 |
Fallers
Company | Price | % Chg |
---|---|---|
Kier Group PLC | 198.20 | -5.62 |
Raspberry Pi Holdings PLC | 442.00 | -4.66 |
International Consolidated Airlines Group S.A. | 367.20 | -3.32 |
Babcock International Group PLC | 1,034.00 | -3.27 |
Melrose Industries PLC | 518.60 | -3.25 |
Just Group PLC | 129.00 | -3.01 |